Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A handful of such cases have been reported since Truvada was approved as pre-exposure prophylaxis in 2012.
The BEAT-HIV Martin Delaney Collaboratory has issued the first comprehensive set of recommendations for such assessments.
People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.
Total payments for the HIV prevention pill exceeded $2 billion in 2018.
The intervention was associated with a higher rate of viral suppression and lower alcohol use when given in a clinic rather than at home.
A recent study analyzed smoking’s ties to substance use and mental, psychological and general health in sexual minority men and trans women.
A recent study in Boston found that only 6% of people at detox centers who tested positive for either virus received follow-up medical care.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
Researchers are surprised and concerned that a strain of HIV that is so broadly resistant to treatment even has the capacity to transmit.
HIV leads to brain inflammation and cognitive decline, but adding marijuana to the mix doesn’t seem to further such damage.
Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.
This finding calls into question research that has projected that frequent testing among men on PrEP could drive down STI rates.
The D-peptide HIV entry inhibitor CPT31 is being developed with hopes it could be injected quarterly for both treatment and prevention.
Plasma from recovered patients recently received a controversial FDA emergency use authorization as a potential treatment for COVID-19.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.